Patents Assigned to LIPHA
  • Patent number: 4156714
    Abstract: A rodenticidal composition comprises a carrier edible by rodents, the surfaces of the pieces of said carrier being coated with a film comprising a film-forming substance and a toxic substance which reduces the level of prothrombin in the blood of a rodent. The compositions are particularly suitable for destroying rats and mice.
    Type: Grant
    Filed: October 28, 1976
    Date of Patent: May 29, 1979
    Assignee: Lipha, Lyonnaise Industrielle Pharmaceutique
    Inventors: Jean-Claude Lechevin, Jean N. Treilles
  • Patent number: 4155993
    Abstract: An orally administrable pharmaceutical composition comprises a dosage of the acid oralate of naftidrofuryl having a prolonged release coating which is a film formed from hydroxypropyl methyl cellulose and ethyl cellulose, the content of ethyl cellulose being between 30 and 50% and containing 8 to 15% of propylene glycol relative to the total of the cellulose derivatives.The composition, having prolonged therapeutic activity is capable of being used in the treatment of arterial diseases in limbs, circulatory disorders in the hands and feet, cerebral vascular disorders and diffuse circulatory insufficiency with elderly people.
    Type: Grant
    Filed: January 13, 1978
    Date of Patent: May 22, 1979
    Assignee: Lipha, Lyonnaise Industrielle Pharmaceutique
    Inventors: Maryse Belleville, Francoise Merle, Jean-Claude Lechevin
  • Patent number: 4122200
    Abstract: Propionic acids and their functional derivatives having anti-inflammatory and analgesic properties correspond to the formula ##STR1## in which X is selected from phenyl, halophenyl, polyhalophenyl, lower alkylphenyl, trihalomethylphenyl, aryloxyphenyl, furyl and thienyl and R is selected from hydrogen, lower alkyl, lower omega-hydroxyalkyl, morpholinoethyl and lower dialkylaminoalkyl.
    Type: Grant
    Filed: August 9, 1977
    Date of Patent: October 24, 1978
    Assignee: Lipha, Lyonnaise Industrielle Pharmaceutique
    Inventors: Philippe Briet, Jean-Jacques Berthelon, Jean-Claude Depin, Eugene Boschetti
  • Patent number: 4110337
    Abstract: A novel class of 4H-5,6-dihydro-[4,3-a]-s-triazolo-1,5-benzodiazepines is disclosed the members of which possess pharmacological activity, particularly analgesic or anti-inflammatory activity, likely to render them of value in the therapeutic field. Intermediates useful in the production of said class of compounds are also disclosed.
    Type: Grant
    Filed: March 8, 1974
    Date of Patent: August 29, 1978
    Assignee: Lipha, Lyonnaise Industrielle Pharmaceutique
    Inventor: Etienne Szarvasi
  • Patent number: 4097582
    Abstract: Propionic acids and their functional derivatives having anti-inflammatory and analgesic properties correspond to the formula ##STR1## in which X is selected from phenyl, halophenyl, polyhalophenyl, lower alkylphenyl, trihalomethylphenyl, aryloxyphenyl, furyl and thienyl and R is selected from hydrogen, lower alkyl, lower omega-hydroxyalkyl, morpholinoethyl and lower dialkylaminoalkyl.
    Type: Grant
    Filed: November 12, 1975
    Date of Patent: June 27, 1978
    Assignee: Lipha, Lyonnaise Industrielle Pharmaceutique
    Inventors: Philippe Briet, Jean-Jacques Berthelon, Jean-Claude Depin, Eugene Boschetti
  • Patent number: 4016285
    Abstract: The compound .alpha.-[6-(2-phenyl)-chromonyl]-acetic acid has choleretic and anti-inflammatory activity and is of use in the treatment of hepatic conditions.
    Type: Grant
    Filed: July 28, 1975
    Date of Patent: April 5, 1977
    Assignee: Lipha, Lyonnaise Industrielle Pharmaceutique
    Inventors: Eugene Boschetti, Philippe Briet, Jean-Jacques Berthelon, Janine Chabert
  • Patent number: 3973033
    Abstract: The present invention relates to substituted tetrahydrofurfuryl aminoesters. The novel tetrahydrofurfuryl dialkyl aminoesters are represented by the formula ##EQU1## in which R is a member of the group formed by the 2-naphthyl, 2-naphthyl substituted in the 6-position with alkoxy and 5,6,7,8-tetrahydro-1-naphthyl radicals. The addition salts with the therapeutically acceptable acids, the starting and intermediate products of these aminoesters, also form the subject of the invention.The novel aminoesters and their salts, endowed with peripheral and cerebral vasodilatory properties, are of particular interest in human therapeutics.
    Type: Grant
    Filed: September 26, 1973
    Date of Patent: August 3, 1976
    Assignee: Lipha, Lyonnaise Industrielle Pharmaceutique
    Inventor: Etienne Szarvasi